Cannabis-based medicinal products linked to sustained improvement in hypermobility-related chronic pain

The study found that treatment with cannabis-based medicinal products was associated with sustained symptomatic improvement in patients with hypermobility-related chronic pain (hypermobility). The research is being noted for its potential relevance to treatment‑resistant pain populations that do not respond to conventional analgesics.

For the full article, please visit the original source link below. CannabisInsight curates and summarizes key news from the global cannabis and hemp industry.